1
|
Penttilä E, Sillanpää S, Vento SI, Myller J, Koskinen A, Hammarén-Malmi S, Laulajainen-Hongisto A, Hytönen M, Lyly A, Lilja M, Kauppi P, Numminen J, Rautiainen M, Sahlman J, Nuutinen M, Toppila-Salmi S, Virkkula P. Eosinophilia, asthma, NERD and the use of oral corticosteroids predict uncontrolled chronic rhinosinusitis with nasal polyps after surgery. Asian Pac J Allergy Immunol 2024; 42:50-60. [PMID: 34542306 DOI: 10.12932/ap-310321-1102] [Citation(s) in RCA: 7] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
BACKGROUND Severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP) is a challenging condition to treat. The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS2020) has the following criteria when considering biological therapy for severe uncontrolled CRSwNP: eosinophilia, need for oral corticosteroids (OCS), symptom score, loss of sense of smell and co-morbid asthma. OBJECTIVE This study aimed at finding associations of baseline factors with uncontrolled CRSwNP after endoscopic sinus surgery (ESS). METHODS Electronic health record data of CRSwNP patients (N = 137) undergoing ESS in 2002-17 were used. Endpoints of uncontrolled CRSwNP were revision ESS, purchased OCS and antibiotic courses during follow up. Baseline factors were chosen based on EPOS2020 and the data available: nasal polyp (NP) eosinophilia, peripheral blood eosinophilia, co-existing asthma and/or non-steroidal anti-inflammatory drug exacerbated respiratory disease (NERD), need for OCS during the previous year, previous ESS, endoscopic NP score, and Lund-Mackay score of sinus computed tomography scans. RESULTS During the follow-up of 10.1 ± 3.1 (mean ± standard deviation) years, 35 (25.5%) individuals underwent revision ESS. The best predictive model was obtained by a sum of baseline (1) blood eosinophilia ≥ 250 cells/≥l and/or NP eosinophilia ≥ 30% (Eos), (2) asthma/NERD, and (3) ≥ 1 OCS/year. It was significantly associated with revision ESS, purchased doctor-prescribed OCS and antibiotic courses during follow-up. CONCLUSIONS We identified similar predictive variables for uncontrolled CRSwNP that are used in the EPOS2020 indications of biological therapy, thus suggesting that these estimates are usable in clinical practice.
Collapse
Affiliation(s)
- Elina Penttilä
- Department of Otorhinolaryngology, Kuopio University Hospital, Kuopio, Finland
- University of Eastern Finland, Kuopio, Finland
| | - Saara Sillanpää
- Department of Otorhinolaryngology - Head and Neck Surgery, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland
| | | | - Jyri Myller
- Department of Otorhinolaryngology, Päijät-Häme Central Hospital, Lahti, Finland
| | | | | | | | | | - Annina Lyly
- University Hospital, Helsinki, Finland
- Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | | | - Paula Kauppi
- Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Department of Pulmonary Diseases, Heart and Lung Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - Jura Numminen
- Department of Otorhinolaryngology - Head and Neck Surgery, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland
| | - Markus Rautiainen
- Department of Otorhinolaryngology - Head and Neck Surgery, Faculty of Medicine and Health Technology, Tampere University and Tampere University Hospital, Tampere, Finland
| | - Johanna Sahlman
- Department of Otorhinolaryngology, Kuopio University Hospital, Kuopio, Finland
| | - Mikko Nuutinen
- Haartman Institute, University of Helsinki, Helsinki, Finland
| | - Sanna Toppila-Salmi
- Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- Haartman Institute, University of Helsinki, Helsinki, Finland
| | - Paula Virkkula
- University Hospital, Helsinki, Finland
- Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| |
Collapse
|
2
|
Lyly A, Laulajainen‐Hongisto A, Turpeinen H, Vento SI, Myller J, Numminen J, Sillanpää S, Sahlman J, Kauppi P, Toppila‐Salmi S. Factors affecting upper airway control of NSAID-exacerbated respiratory disease: A real-world study of 167 patients. Immun Inflamm Dis 2021; 9:80-89. [PMID: 33400396 PMCID: PMC7860608 DOI: 10.1002/iid3.347] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2020] [Revised: 08/14/2020] [Accepted: 08/24/2020] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease (N-ERD) is a triad with asthma, chronic rhinosinusitis with nasal polyps, and NSAID intolerance. Uncontrolled N-ERD forms a major public health problem due to frequent and difficult-to-treat exacerbations and/or requiring putatively frequent endoscopic sinus surgeries (ESS). Our aim was to study factors affecting control of N-ERD. METHODS Retrospective patient record data (patient characteristics, prior sinus surgeries, follow-up data in 2020) from 167 N-ERD patients undergoing consultation at three tertiary hospitals from 2001 to 2017 was used. Outcome measurements reflecting uncontrolled N-ERD were revision ESS, corticosteroids/biological therapy, and antibiotic courses during 2016-2020. Associations were analyzed by using nonparametric tests, Cox's proportional hazard, and binary logistic regression models. RESULTS Nasal polyp eosinophilia increased the risk of revision surgery during the follow-up (adjusted hazard ratio [aHR] 3.21, confidence interval 1.23-8.38). Also baseline oral corticosteroids (OCS; HR, 1.73, 1.04-2.89) and baseline surgery without total ethmoidectomy increased the risk of revision ESS (HR, 2.17, 1.07-4.42) in unadjusted models. In addition, both baseline OCS (adjusted odds ratio [aOR] 2.78, 1.23-6.26) and a history of ≥4 previous ESS (aOR, 2.15, 0.98-4.70) were associated with the use of OCS/biological therapy during the follow-up, but not with high number of antibiotics. CONCLUSIONS Nasal polyp eosinophilia, baseline OCS, and a history of recurrent ESS predict uncontrolled N-ERD. These factors might be clinically useful in risk-estimation of uncontrolled disease and for organizing follow-ups. Prospective cohort studies with larger sample size are needed to further study the factors affecting the upper airway control of N-ERD.
Collapse
Affiliation(s)
- Annina Lyly
- Inflammation Center, Skin and Allergy HospitalUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
- Department of Otorhinolaryngology—Head and Neck SurgeryUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
| | - Anu Laulajainen‐Hongisto
- Inflammation Center, Skin and Allergy HospitalUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
- Department of Otorhinolaryngology—Head and Neck SurgeryUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
| | - Heikki Turpeinen
- Inflammation Center, Skin and Allergy HospitalUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
| | - Seija I. Vento
- Department of Otorhinolaryngology—Head and Neck SurgeryUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
| | - Jyri Myller
- Department of OtorhinolaryngologyPäijät‐Häme Central HospitalLahtiFinland
| | - Jura Numminen
- Department of OtorhinolaryngologyUniversity of Tampere, Faculty of Medicine and Life Sciences and Tampere University HospitalTampereFinland
| | - Saara Sillanpää
- Department of OtorhinolaryngologyUniversity of Tampere, Faculty of Medicine and Life Sciences and Tampere University HospitalTampereFinland
| | - Johanna Sahlman
- Department of OtorhinolaryngologyKuopio University HospitalKuopioFinland
| | - Paula Kauppi
- Inflammation Center, Skin and Allergy HospitalUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
| | - Sanna Toppila‐Salmi
- Inflammation Center, Skin and Allergy HospitalUniversity of Helsinki and Helsinki University HospitalHelsinkiFinland
- Medicum, Haartman InstituteUniversity of HelsinkiHelsinkiFinland
| |
Collapse
|
3
|
Virkkula P, Penttilä E, Vento SI, Myller J, Koskinen A, Hammarén-Malmi S, Laulajainen-Hongisto A, Hytönen M, Lilja M, Numminen J, Sillanpää S, Sahlman J, Toppila-Salmi S. Assessing Cut-off Points of Eosinophils, Nasal Polyp, and Lund-Mackay Scores to Predict Surgery in Nasal Polyposis: A Real-World Study. Allergy Rhinol (Providence) 2020; 11:2152656720956596. [PMID: 35141001 PMCID: PMC8819805 DOI: 10.1177/2152656720956596] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Background Developing tools to identify chronic rhinosinusitis with nasal polyps
(CRSwNP) patients requiring surgical treatment would help clinicians treat
patients more effectively. The aim of this retrospective cross-sectional
study was to identify cut-off values for eosinophil percentage, nasal
polyps (NP), and Lund-Mackay (LM) scores that may predict the need for
surgical treatment in Finnish CRSwNP patients. Methods Data of CRSwNP patients (N = 378) undergoing consultation for ESS in 2001–19
were used. Data was collected from patient records and Lund-Mackay scores
were determined from sinus computed tomography scans. The percentage of
eosinophils was microscopically evaluated from the polyp samples available
(n = 81). Associations were analyzed by Mann Whitney U test, and cut-off
values by the area under the receiver operating characteristic curve
(AUROC). Results ESS was performed to 293 (77.5%) of patients. Polyp eosinophilia was
associated significantly with ESS (p = 0.001), whereas peripheral blood
eosinophil count, LM- score and endoscopic NP- score were not (p > 0.05).
AUROC values (95% CI) for detecting those needing ESS were for polyp
eosinophilia 0.71 (0.60–0.83), p = 0.001, for LM score 0.59 (0.50–0.67),
p = 0.054; for NP score 0.56 (0.48–0.64), p = 0.17, and for blood eosinophil
count 0.68 (0.46–0.90), p = 0.08. With the threshold value of polyp
eosinophilia (>25%), the sensitivity and specificity were optimal for
detecting the group needing ESS from the group not undergoing ESS. The
cut-off value of blood eosinophil count (>0.26 × 109/L) had
relatively good, yet statistically insignificant (underpowered), predictive
potential. Moderate cut-off values were found for endoscopic LM score
(≥14/24) and NP score (≥4/8). Conclusions Polyp eosinophilia (>25%) predicted ESS among Finnish hospital-level
CRSwNP patients. A future challenge would be to find less invasive and
cost-effective clinical factors predicting uncontrolled CRSwNP.
Collapse
Affiliation(s)
- P Virkkula
- Department of Otorhinolaryngology-Head and Neck surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - E Penttilä
- Department of Otorhinolaryngology, University of Eastern Finland, Kuopio, Finland.,Department of Otorhinolaryngology, Kuopio University Hospital, Kuopio, Finland
| | - S I Vento
- Department of Otorhinolaryngology-Head and Neck surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - J Myller
- Department of Otorhinolaryngology, Päijät-Häme Central Hospital, Lahti, Finland
| | - A Koskinen
- Department of Otorhinolaryngology-Head and Neck surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - S Hammarén-Malmi
- Department of Otorhinolaryngology-Head and Neck surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - A Laulajainen-Hongisto
- Department of Otorhinolaryngology-Head and Neck surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - M Hytönen
- Department of Otorhinolaryngology-Head and Neck surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - M Lilja
- Department of Otorhinolaryngology-Head and Neck surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - J Numminen
- Department of Otorhinolaryngology, University of Tampere, Tampere, Finland.,Faculty of Medicine and Life Sciences and Tampere University Hospital, Tampere, Finland
| | - S Sillanpää
- Department of Otorhinolaryngology, University of Tampere, Tampere, Finland.,Faculty of Medicine and Life Sciences and Tampere University Hospital, Tampere, Finland
| | - J Sahlman
- Department of Otorhinolaryngology, Kuopio University Hospital, Kuopio, Finland
| | - S Toppila-Salmi
- Department of Allergy, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.,Haartman Institute, University of Helsinki, Helsinki, Finland
| |
Collapse
|
4
|
Lundberg M, Haapaniemi A, Hagstrom J, Juteau S, Hernberg M, Makitie AA, Vento SI. Similar survival outcome after endoscopic and open approaches for sinonasal mucosal melanoma. Rhinology 2019; 57:132-138. [PMID: 30471227 DOI: 10.4193/rhin18.123] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
BACKGROUND To describe a cohort of sinonasal mucosal melanoma (SNMM) patients, and to assess if choice of surgical approach (open versus endoscopic) has impact on survival. METHODOLOGY Adequate data on clinical presentation, treatment, and recurrence pattern were available for 58 consecutive patients treated for SNMM at the Helsinki University Hospital (HUH) between 1983 and 2016. RESULTS The 5-year disease-specific survival (DSS) was 27% and overall survival 25% for the whole cohort. The 3-year DSS for patients treated with curative intent with endoscopic surgery was comparable to open surgery (56% and 51%, respectively). Patients with tumours arising from the paranasal sinuses and patients with Stage IV disease had significantly worse prognosis compared with other locations and Stage III patients. All patients who had disease persistence at three months after primary treatment succumbed to SNMM. Post-operative radiotherapy did not affect survival significantly, but a trend towards improved local control was observed. CONCLUSIONS Local control after endoscopic surgery was comparable to open surgery. Small tumours without local or locoregional spread had improved prognosis, independent of surgical approach. Disease persistence after treatment with curative intent led to death invariably.
Collapse
Affiliation(s)
- M Lundberg
- Department of Otorhinolaryngology â€" Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - A Haapaniemi
- Department of Otorhinolaryngology â€" Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - J Hagstrom
- Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - S Juteau
- Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - M Hernberg
- Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
| | - A A Makitie
- Department of Otorhinolaryngology â€" Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Division of Ear, Nose and Throat Diseases, Department of Clinical Sciences, Intervention and Technology, Karolin
| | - S I Vento
- Department of Otorhinolaryngology â€" Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| |
Collapse
|
5
|
Hafrén L, Pajari M, Vento SI, Saarinen R. Otitis media with effusion in aspirin-exacerbated respiratory disease patients-A series of 22 cases. Clin Otolaryngol 2018; 43:1387-1391. [PMID: 29802678 DOI: 10.1111/coa.13150] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/23/2018] [Indexed: 11/29/2022]
Affiliation(s)
- L Hafrén
- Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University and Helsinki University Hospital, Helsinki, Finland
| | - M Pajari
- South Karelia Central Hospital, Lappeenranta, Finland
| | - S I Vento
- Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University and Helsinki University Hospital, Helsinki, Finland
| | - R Saarinen
- Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University and Helsinki University Hospital, Helsinki, Finland
| |
Collapse
|
6
|
Virkkula P, Mäkitie AA, Vento SI. Surgical outcome and complications of nasal septal perforation repair with temporal fascia and periosteal grafts. Clin Med Insights Ear Nose Throat 2015; 8:7-11. [PMID: 25987852 PMCID: PMC4416539 DOI: 10.4137/cment.s23230] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/06/2015] [Revised: 02/17/2015] [Accepted: 03/04/2015] [Indexed: 11/05/2022]
Abstract
AIMS Surgical treatment of nasal septal perforation remains a challenging field of rhinology. A large variety of techniques and grafts with promising results have been introduced for perforation repair. However, the use of fascia or fascia with periosteum has not been previously evaluated for a large sample of patients. METHODS During the years 2007–2014, 105 operations were performed and 98 patients were treated for nasal septal perforation at the Department of Otorhinolaryngology—Head and Neck Surgery, Helsinki University Hospital, Helsinki, Finland. We performed a retrospective review of closure rates and complications. Follow-up time ranged from 1 to 62 months. RESULTS Bleeding was the most common early complication (9%), followed by postoperative infection (5%) in the whole series. Our main technique, bipedicled advancement flaps with fascia or fascia and periosteum, was performed for 81 patients. We obtained successful closure in 78% of these patients with this operative technique and the rate increased to 86% during the last 3 years of the study period. CONCLUSIONS Perforation repair with temporal fascia or fascia with periosteum requiring only one donor site seems to be a reliable option for nasal septal perforation repair.
Collapse
Affiliation(s)
- Paula Virkkula
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - Antti A Mäkitie
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| | - Seija I Vento
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
| |
Collapse
|
7
|
Vento SI, Tahkokallio O, Seppänen M, Hytönen M. Dose escalation of montelukast in the treatment of nine patients with nasal polyposis: an open pilot study: our experience. Clin Otolaryngol 2014; 39:375-9. [PMID: 24990512 DOI: 10.1111/coa.12281] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/29/2014] [Indexed: 11/28/2022]
Affiliation(s)
- S I Vento
- Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
| | | | | | | |
Collapse
|
8
|
Videler WJ, Badia L, Harvey RJ, Gane S, Georgalas C, van der Meulen FW, Menger DJ, Lehtonen MT, Toppila-Salmi SK, Vento SI, Hytönen M, Hellings PW, Kalogjera L, Lund VJ, Scadding G, Mullol J, Fokkens WJ. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy 2011; 66:1457-68. [PMID: 21884529 DOI: 10.1111/j.1398-9995.2011.02693.x] [Citation(s) in RCA: 130] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND In persistent chronic rhinosinusitis (CRS), conventional treatment is often insufficient. Long-term, low-dose administration of macrolides has been suggested as a treatment option. The MACS (Macrolides in chronic rhinosinusitis) study is a randomized placebo-controlled trial evaluating the efficacy of azithromycin (AZM) in CRS. METHODS We describe a group of patients with recalcitrant CRS with and without nasal polyps unresponsive to optimal medical and (in 92% also) surgical treatment. Patients were treated with AZM or placebo. AZM was given for 3 days at 500 mg during the first week, followed by 500 mg per week for the next 11 weeks. Patients were monitored until 3 months post-therapy. The assessments included Sino-Nasal Outcome Test-22 (SNOT-22), a Patient Response Rating Scale, Visual Analogue Scale (VAS), Short Form-36 (SF-36), rigid nasal endoscopy, peak nasal inspiratory flow (PNIF), Sniffin' Sticks smell tests and endoscopically guided middle meatus cultures. RESULTS Sixty patients with a median age of 49 years were included. Fifty per cent had asthma and 58% had undergone revision sinus surgery. In the SNOT-22, Patient Response Rating Scale, VAS scores and SF-36, no significant difference between the AZM and the placebo groups was demonstrated. Nasal endoscopic findings, PNIF results, smell tests and microbiology showed no relevant significant differences between the groups either. CONCLUSION At the investigated dose of AZM over 3 months, no significant benefit was found over placebo. Possible reasons could be disease severity in the investigated group, under-dosage of AZM and under-powering of the study. Therefore, more research is urgently required.
Collapse
Affiliation(s)
- W J Videler
- Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, the Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Peltonen LI, Vento SI, Simola M, Malmberg H. Effects of the nasal strip and dilator on nasal breathing--a study with healthy subjects. Rhinology 2004; 42:122-5. [PMID: 15521663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/01/2023]
Abstract
OBJECTIVE To investigate effects of the nose dilating devices on nasal anatomy and breathing in healthy subjects. MATERIALS AND METHODS 27 healthy subjects were tested when using the Breathe Right nasal strip or the Nozovent dilator. Posterior rhinomanometry, acoustic rhinometry, and a subjective evaluation were used as methods. RESULTS Both devices significantly increased the minimum cross-sectional area of the nasal valve and decreased nasal resistance. The Nozovent dilator proved to be significantly more effective in reducing nasal resistance than the Breathe Right nasal strip. CONCLUSIONS Nose dilating devices, the Breathe Right nasal strip and the Nozovent dilator, can be used to reduce nasal resistance. More studies are needed to evaluate the usefulness of the devices for patients with chronic obstruction for any reason in the valve area.
Collapse
Affiliation(s)
- Lauri I Peltonen
- Department of Otorhinolaryngology, Helsinki University Central Hospital, Helsinki, Finland.
| | | | | | | |
Collapse
|
10
|
Hytönen M, Patjas M, Vento SI, Kauppi P, Malmberg H, Ylikoski J, Kere J. Cystic fibrosis gene mutations deltaF508 and 394delTT in patients with chronic sinusitis in Finland. Acta Otolaryngol 2001; 121:945-7. [PMID: 11813900 DOI: 10.1080/000164801317166835] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Previous studies have shown that cystic fibrosis (CF) gene mutations are linked to several severe chronic infections. Chronic sinusitis is one condition that may well be influenced by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. We studied two prevalent CF mutations (AF508 and 394delTT) in a population with a low incidence of CF. The carrier frequency of the CF mutations in the Finnish population is approximately 1 in 80. We examined DNA specimens from 127 chronic sinusitis patients and found one patient who was heterozygous for 394delTT gene mutation. None of the DNA specimens had any AF508 mutation. This study shows that in a population with a low incidence of CF there was no abnormal carrier distribution of the two most common CF gene mutations in a group of chronic sinusitis patients. Routine screening of sinusitis patients for CF mutations provides no additional information on the etiology of chronic sinusitis.
Collapse
Affiliation(s)
- M Hytönen
- Helsinki University ENT Hospital, Helsinki University Central Hospital, Finland
| | | | | | | | | | | | | |
Collapse
|
11
|
Abstract
An impaired sense of smell is a common complaint in patients with nasal polyposis, and hyposmia is usually attributed to obstruction of the nasal airways. The duration of nasal polyposis and nasal surgery may also affect olfaction. It has been shown that aging and chronic rhinitis both impair olfaction. The aim of our study was to evaluate the sense of smell in patients who had had nasal polyposisfor at least 20 years. The olfactory threshold was assessed with a commercially available odor detection threshold test. The threshold of 19 (46%) of 41 patients was greater than the age-related upper 95% reference limit. In a forward stepwise multiple regression analysis of all the polyposis patients, the degree of opacity of ethmoidal sinuses seen in computed tomography (CT), polyposis visible in anterior rhinoscopy, total nasal resistance, and gender had a significant association with olfactory threshold.
Collapse
Affiliation(s)
- S I Vento
- Department of Otorhinolaryngology, Helsinki University Central Hospital, Finland
| | | | | | | |
Collapse
|
12
|
Vento SI, Wolff CH, Salven PJ, Hytönen ML, Ertama LO, Malmberg CH. Vascular permeability factor/vascular endothelial growth factor in nasal polyps. Acta Otolaryngol Suppl 2001; 543:170-4. [PMID: 10909012 DOI: 10.1080/000164800454314] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Although the aetiology of polyps is still, for the most part, unknown, the disease is known to involve tissue oedema. Vascular permeability/vascular endothelial growth factor (VPF/VEGF) is a major inducer of angiogenesis and capillary permeability. This study investigated VPF/VEGF expression in biopsies of nasal polyps from 39 patients and in healthy nasal mucosa from 10 patients by immunohistochemical staining. Staining for VPF/VEGF in the mucosal surface and in the glandular epithelium of nasal polyps was weaker than in normal controls. In two patients, strong staining for VPF/VEGF was found in a granular pattern in mast cells, while the mast cells in other polyposis patients appeared to be largely degranulated. VPF/VEGF was not seen in the mast cells of control patients. Although expression of VPF/VEGF was not increased in the epithelium of the nasal polyps, VPF/VEGF secreted from mast cells may take part in nasal polyp formation.
Collapse
Affiliation(s)
- S I Vento
- Department of Otorhinolaryngology, Helsinki University Central Hospital, Finland.
| | | | | | | | | | | |
Collapse
|
13
|
Abstract
BACKGROUND The etiology of nasal polyposis is mainly unknown although it has been connected with many clinical conditions. The long-term clinical course of nasal polyposis is largely unknown, because long-term followup studies on the recurrence of nasal polyposis have rarely been reported. OBJECTIVE The aim of the study was to find out the clinical course of nasal polyposis over a long period of time. PATIENTS AND METHODS Our report describes a 20-year follow-up study of 41 patients with nasal polyps. These patients had surgery for nasal polyp disease 20 years previously and they were initially grouped according to occurrence of (1) acetylsalicylic acid (ASA) intolerance, (2) atopic allergy (AT), and (3) intrinsic allergy-like disease (INTR). Patients were now re-examined, sinus computed tomography (CT) scanning was made, and a biopsy from polyp or from mucosa of the middle turbinate was taken. RESULTS Anterior rhinoscopy revealed polyps in 35 of 41 patients. Thus nasal polyposis was still active in 85% of patients after 20 years. Mucosal changes in paranasal sinuses were found in every patient. Anosmia or hyposmia was found in 61% (25/41) of the patients. Eight patients had had 11 or more surgical operations during the 20-year period. Of these, 88% (7/8) belonged to the ASA group. Bronchial asthma was found in all ASA intolerance patients (11/11), and in 36% (4/11) of AT and in 16% (3/19) of INTR patients, respectively. CONCLUSION Because of the high recurrence tendency and insidious symptoms of nasal polyposis, patients will require followup for the rest of their lives.
Collapse
Affiliation(s)
- S I Vento
- Department of Otorhinolaryngology, Helsinki University Central Hospital, Finland.
| | | | | | | | | |
Collapse
|
14
|
Abstract
A-mode ultrasound (A-US) is a simple, non-invasive and non-ionizing method for detecting fluid or even mucosal swelling in inflamed maxillary and frontal sinuses. A-US has been shown to be a quite reliable tool in the diagnosis of acute maxillary sinusitis. However, controversy still exists over the reliability of A-US in detecting fluid retention or mucosal swelling in patients suffering from chronic polypous rhinosinusitis or in transantrally operated maxillary sinuses. We have compared the results of maxillary sinus A-US with computed tomography (CT) images in a selected series of chronic polypous rhinosinusitis comprising 40 patients. Fluid retention was seen in 20 of 79 maxillary sinuses on CT scanning. Only 6 of these 20 retentions were detected with A-US. There were 11 false positive findings. In six of these cases a back-wall echo was received through polypoid masses in the sinus. Mucosal swelling was also difficult to diagnose. The results of A-US were not easily reproduced; only in 50% of cases were identical results obtained by two investigators. We do not recommend the use of A-US to diagnose fluid retention or mucosal swelling in a patient with chronic mucosal changes in the maxillary sinus or if surgery has been performed on the anterior wall of the maxillary sinus.
Collapse
Affiliation(s)
- S I Vento
- Department of Otorhinolaryngology, Helsinki University Central Hospital, Finland.
| | | | | | | |
Collapse
|